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ABSTRACT
 
Background: Hemichorea-hemiballismus (HC-HB) 
is a hyperkinetic disorder of  uncontrolled movements 
mostly in the proximal extremity on one side of the 
body. The most common cause is acute 
cerebrovascular disorder. The second is Non-ketotic 
hyperglycemia. This case is rare and the prevalence is 
unknown. Case: A 60-year-old female came with 
involuntary, repetitive, and non rhythmic movements 
in the left arm and leg. She had a history of 
uncontrolled type 2 diabetes mellitus and 
hypertension. Head CT-scan showed hyperdense 
lesions in the right basal ganglia and infarction in the 
right temporal lobe. Symptoms improved after blood 
glucose had been controlled by basal and prandial 
insulin. Discussion: HC-HB is often caused by lesions 
in basal ganglia and contralateral subthalamic nucleus. 
Clinical manifestations of the patient supports non-
ketotic hyperglycemia and basal ganglia hyperdensity. 
Conclusion: The prognosis of HC-HB is good in most 
patients with or without treatment. This case report 
describes a successful treatment approach with 
positive results in fairly short duration.
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Background   
The most common etiology of hemichorea-
hemiballismus (HC-HB) is acute cerebrovascular 
disorder,1,2 followed by non-ketotic 
hyperglycemia.2 However, this case is quite 
rare.3,4 Diabetes mellitus (DM) is an endocrine 
disorder that most often occurs in Indonesia. 
Stroke and neuropathy is some of the most 
common long term complications of DM, 
especially in uncontrolled DM. Complications on 
neurovascular system can involve the brain, spinal 
cord, cranial nerves, autonomic nervous system, 
or peripheral nervous system.3 However, HC-HB 
is not the same as other neurological 
complications, because its complexity, so it 
becomes a challenge for doctors to be diagnosed 
as one of the complications of diabetes. If there is 
a part of the structure of the brain neurons 
involved, the patient can present with symptoms 
of choreiform and HC-HB is one of the 
choreiform type that can be a manifestation of 
hyperglycemia due to uncontrolled DM.4,5 The 
following cases are rare and the prevalence is still 
unknown. 
 
Case Report 
A 60-year-old female is admitted to hospital with 
symptoms of arms and legs moving involuntarily 
since 15 days ago. Movement occurs on the left 
side of upper and lower limb, especially in the 
proximal part. Movement that appears like 
jerking, hitting and dancing roughly. The first 
movement appears right after she woke up and the 
movement cannot be controlled by the patient. 
Abnormal movements improve when the patient 
sleeps, but when she woke up the movement 
reappears. The patient has just been diagnosed 
with diabetes mellitus 2 weeks before and have 
not taken anti diabetic medications. Patients also 
have a history of hypertension for 1 year but did 
not take medication as well. On the physical 
examination, the patient was fully alert with 
Glasglow Coma Scale (GCS) E4V5M6. Blood 
pressure was 140/90 mmHg, heart rate was 
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 84x/minute regular, respiratory rate was 
18x/minutes, temperature 36.70C. Cranial nerve 
examination is normal and no pathological reflex 
is found in the patient. Involuntary movement was 
observed in examination. It was not rhythmical, 
fast, repetitive and continues like jerking and 
dancing roughly on the left side of the upper and 
lower of proximal extremities. Laboratory tests 
were performed on patients, blood glucose was 
622 mg/dl, fasting blood glucose 270 mg/dl, urea 
57 mg/dl, serum creatinine 0.53mg/dl. Blood 
examination showed leukocytosis (12,100/mmk). 
There was mild 
hyponatremia(132.5mmol/L),hypochloremia(86.
7mmol/L). The potassium and calsium level 
(4.25mmol/L and 2.22mmol/L) were within 
normal range. Complete urine result is also within 
normal limit and there is no ketonuria. Lipid 
profile was normal. Non-contrast brain computed 
tomography (CT) was performed in patients and 
there was hyperdensity in right basal ganglia and 
ongoing infarction in right temporal lobe.<Figure 
1>. 
 
 
Figure 1. Non-contrast computed tomography scan of the patients shows (A, arrow) hyperdensity in 
right basal ganglia and (B, arrow) on going infarction in right temporal lobe 
Based on clinical symptoms and patient history, 
the cause of hemiballismus in this patient is 
suspected to be related to the history of 
uncontrolled type 2 diabetes mellitus. Then the 
patient was hospitalized. Blood glucose control, 
symptomatic and supportive therapy was given. 
We also monitored for other accompanying 
symptoms. The patient was given citicolin 
intravenous 2x500 mg, Aspirin 1x80 mg PO, 
clobazam 2x10 mg PO, haloperidol 2x1.5 mg PO. 
Insulin therapy was also given to this patient, with 
basal insulin dose of 14 IU and 3x6 IU of rapid 
acting insulin. The patient's blood glucose was 
monitored every day. Patients were treated for 10 
days at Bangli General Hospital and discharged 
after the conditions are stabilized and the blood 
glucose is normal. After 3 months of follow-up, 
with regular control once every month, the 
patient's involuntary movement showed very 
significant improvement. The involuntary 
movement was resolved completely. 
 
Discussion  
Hemichorea-hemiballismus (HC-HB) is one of 
the most common types of choreiform involuntary 
movements. 3,4 HC-HB is a hyperkinetic disorder 
which is characterized by movements that are 
uncontrolled, non-rhythmical, and often occur in 
the proximal limb, in one side of the body. HC-
HB occurs due to interference on the contralateral 
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basal ganglia, especially in the striatum area. HC-
HB is mainly caused by the presence of systemic 
processes, both focal and diffuse.6 Focal processes 
include  
infections of the central nervous system such as 
encephalitis, toxoplasmosis,vasculitis, stroke, 
cysts, neoplasms, tuberculomas, any vascular 
malformations, neurodegenerative disorders, and 
demyelinating plaques.6,7 Diffuse systemic 
processes can include non-ketotic hyperglycemia, 
hyperparathyroidism, autoimmune disorders such 
as Lupus, Wilsons disease, and thyrotoxicosis.5 
Other causes of HC-HB can be due to the use of 
drugs such as levodopa, phenytoin and oral 
contraception.4 Hemiballismus can classified as 
primary or acquired.4 Hyperglycemia or 
hypoglycemia, hypernatremia and hyponatremia, 
hypomagnesemia, and hypocalcemia can be the 
metabolic causes of acquired hemiballismus. 
However, these cases are rare.8 
Diabetes mellitus is a disease that disrupts glucose 
metabolism which can lead  to conditions of 
hyperglycemia and this chronic disease is 
associated with chronic inflammation and can 
cause various systemic complications. HC-HB 
can be manifested as an initial symptom or 
complication of DM. HC-HB is the main 
symptom in this case. Non-ketotic hyperglycemia 
can occur with a variety of neurological symptoms 
including hyperosmolar coma, seizures, and 
hemichorea-hemibalismus(HC- HB).4 In this 
patient, it can be observed that patient's control of 
her glucose levels is poor and as a result of a very 
high and chronically increase in serum blood 
glucose level, blood hyperviscosity happened, 
which eventually causes ischemia in the basal 
ganglia and causes a decrease in the production of 
gamma-butyric acid (GABA) and acetylcholine at 
basal ganglia.2,9 This causes disruption of impulse 
transmission. The dopaminergic activity 
increased very high due to loss of inhibitor factors, 
resulting in continuous and irregular jerking of 
thelimbs. This patient also has on going acute 
ischemic stroke, so the cause of HC-HB in this 
patient is more likely combination between 
metabolic cause which is type 2 diabetes mellitus 
and the ischemic stroke.   
Non-ketotic hyperglycemia is known to be a 
metabolic cause of HC-HB, especially in elderly 
patients with uncontrolled diabetes mellitus. The 
underlying pathophysiology is not fully 
understood. Different mechanisms have been 
hypothesized. Acute putamen dysfunction, 
protein dissociation or denaturation after the 
occurrence of the wallerian degeneration is one of 
the most trusted mechanisms behind imaging 
findings. Petechial bleeding, microcalcifications, 
edema, reactive astrocytes, and interneuronal 
responses have been studied as a possible 
hypothesis.2 Several other mechanisms have also 
been suggested to explain the pathophysiology of 
the occurrence of this syndrome, including acute 
infarction, microhemorrhagic in basal ganglia, or 
injury secondary to hyperviscosity and vasogenic 
edema. Hypoperfusion of cerebral blood flow to 
the basal ganglia, GABA and acetylcholine 
depletion, metabolic acidosis, many deposition 
products of myelin breakdown, deposits of 
calcium and other minerals are other hypothesized 
etiologies.10 The most accepted theory of HC-HB 
is hypoperfusion due to blood hyperviscosity 
caused by by the condition of hyperglycemia 
which increases anaerobic metabolism by 
reducing GABA levels.2,11 MRI is an examination 
that is recommended to assess changes in the 
putamen and caudate nucleus.2,4 The presence of 
T1 hyperintensity is the most common finding. In 
peripheral areas that does not have MRI, CT-scan 
can be done. In CT scan, hyperdensity of basal 
ganglia and subtle hyperdensity in the striatal area 
can also be found. The pathophysiological 
mechanism underlying the findings on imaging is 
controversial. These typical findings on imaging 
are thought to be the result of hemorrhagic 
processes. But according to the neuropathology 
study by Ohara et al, in this finding there is only 
found astrocytosis without hemosiderin deposits. 
So it is hypothesized that the imaging findings 
result from progressive pathological reactions 
during infarction process and it means that these 
findings are more related to the presence of blood 
vessel disorders than petechial bleeding or 
hyperglycemia.12 
Vascular and structural lesions in the contralateral 
subthalamic nucleus and basal ganglia are the 
most common causes of HC-HB. Non-
hemorrhagic and hemorrhagic stroke are the most 
common etiologies. Although stroke is the most 
frequent etiology of HC-HB, the incidence of HC-
HB as a clinical manifestation compared to other 
manifestations that occur in stroke is very low. 
Arboix et al. reported that of 2,500 stroke patients, 
only 2 patients had HC-HB as clinical 
manifestations. 13 Transient HC-HB associated 
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 with non-ketotic hyperglycemia is another very 
important etiology because it is the second most 
common cause of HC-HB.14 This syndrome is 
characterized by the onset of chorea / ballismus 
during hyperglycemic episodes. Blood glucose 
ranges from 500 - 1000 mg/dL during crisis of 
hyperglycemic. Movement that arises is usually 
unilateral, but can arise generalized in rare cases. 
Clinical manifestations of movement can vary 
from mild chorea to severe ballismus. In a review 
of 53 cases, Oh et al. showed that the average age 
of onset was 71, with female dominance 1.8: 1.15 
Genetic factors play a role with Asian dominance 
in reported cases.15,16 Characteristic findings on 
MRI and CT-scan for basal ganglia hyperdensity 
seen in almost allcases. 
Management of the patient can be achieved by 
normalizing blood glucoselevels,although lesions 
on imaging can take up to 6 months to show 
improvement. 17 In refractory and severe cases, 
haloperidol, risperidone, topiramate, and 
benzodiazepines can be used, especially with any 
atypical antipsychotics. 4 In general , the 
prognosis is very good if it can be identified and 
given management as early as possible. In this 
case, the HC- HB symptom that occurs is typically 
associated with a condition of non-ketotic 
hyperglycemia in type 2 diabetes mellitus. 
Management of patient gradually by controlling 
the state of hyperglycemia. 
HC-HB can improve over time and often no 
specific treatment is needed. Determining 
etiology is the most important in the management 
of HC-HB, such as optimal blood sugar 
management, overcoming existing structural 
lesions or infection.14 Patients with HC-HB 
secondary to acute stroke require evaluation and 
management of stroke therapy. In patients with 
HC-HB due to non ketotic hyperglycemia, the 
main therapy is controlling blood glucose, along 
with long-term control of diabetes.15 
Management of pharmacology has a role in 
preventing injury when severe ballismus 
movements occur, and treating patients with 
chronic HC-HB. Based on several studies, 
levodopa often worsens the symptoms of chorea. 
Early treatment with dopamine receptor blocking 
agents (chlorpromazine or haloperidol) in patients 
with HC- HB is declared successful.1 General 
management of HC-HB often accompanied by 
neuroleptic drugs (haloperidol, metachlopromide, 
olanzapine), dopamine-depleting agent 
(tetrabenazine, reserpine), and GABA-ergic drugs 
(clonazepam, gabapentin) .6,18 Over the past 
three decades, neuroleptics have become the main 
pharmacological therapy for HC-HB. Vidakovic 
et al. reported 19 of 25 patients with 
hemiballismus treated with haloperidol 
successfully showed improvement.19 Pimozide 
and benzodiazepines are also often used. 
According to recent research, agents that reduce 
dopamine have been reported to show much better 
benefits. Tetrabenazine, which reduces the 
production of presynaptic 
dopamine,norepinephrine,serotonin,and 
postsynaptic dopamine receptor antagonists has 
been shown to be more useful in the treatment of 
HC-HB secondary to stroke or non ketotic 
hyperglycemia.20 Another benefit of tetrabenazine 
is a reduced risk of tardive dyskinesia compared 
to any typical and any atypical neuroleptics. Drug 
induced parkinsonism is the most common 
complication caused by the use of dopamine 
inhibiting agents or agents that reduce dopamine 
production.14 
In the case of refractory HC-HB that is not 
responsive to treatment, stereotactic surgery and 
deep brain stimulation (DBS) can be very 
effective in controlling the movement of HC-HB. 
Contralateral (ventrolateral) thalamotomy and 
pallidotomy (posterioventral) have been 
successful.1 Another option of surgery in rare 
cases is carotid endarterectomy for new onset HC-
HB and evidence of contralateral carotid stenosis 
(more than 70% is blocked).21 
HC-HB is often temporary and can recover 
without the need of specific management. In an 
observational study of 15 patients with post-stroke 
HC-HB, 53% experienced fast resolution without 
treatment, and 73% experienced complete 
resolution of symptoms after 17 months.22 
However, this case illustrates the need of early 
identification and adequate treatment when HC-
HB does not spontaneously recover quickly and 
has a negative impact on the patient's safety and 
function. Haloperidol is often needed for the 
treatment of patients with HC- HB, although it is 
not enough to treat it perfectly. In this patient the 
functional improvement was shown after starting 
low-dose haloperidol, benzodiazepines, and well 
controlled of blood glucose level. Daily 
monitoring is required in this condition, so the 
patient was hospitalized and we stabilized the 
blood glucose level. We measured fasting glucose 
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level and random glucose level everyday until 
target achieved (<200 mg/dl). Monitoring vital 
and clinical signs also required to assess 
worsening or improvement of the symptoms. The 
patient was hospitalized for 10 days and routine 
evaluation once every month is recommended. 
After 3 months of follow up, the patient showed 
significant improvements. 
 
Conclusion  
Hemichorea-hemiballismus (HC-HB) is a rare 
condition. Many etiologies can cause this 
disorder, but vascular disorders and non-ketotic 
hyperglycemia are the most common etiologies. 
HC-HB in non-ketotic hyperglycemic is very rare 
manisfestation in diabetes mellitus. The prognosis 
is quite good in most patients with good glucose 
control. This case report describes a successful 
treatment approach with positive results in fairly 
short duration.
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